179082-63-4

Upstream product

• 103-71-9 phenyl isocyanate 
• 179083-28-4 (R)-4-tert-Butoxycarbonylamino-4-{[(isopropyl-phenyl-carbamoyl)-methyl]-phenyl-carbamoyl}-butyric acid tert-butyl ester 
• 13726-84-6 (tert-butoxy)carbonyl-D-glutamic acid 5-tert-butyl ester 
• 179083-21-7 (R)-4-tert-Butoxycarbonylamino-4-phenylcarbamoyl-butyric acid tert-butyl ester 
• 62-53-3 aniline 

Relevant academic research and scientific papers

Oxoazepine derivatives

This invention relates to novel oxoazepine derivatives of Formula (I), to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine. More particularly, it relates to compounds which exhibit agonist ac

Conversion of acyclic nonpeptide CCK antagonists into CCK agonists

The CCK antagonists RP 69758 and (R)-lorglumide were converted into CCK agonists by the introduction of an N-isopropylanilide agonist 'trigger'. The common structural features of these ligands suggest that nonpeptide agonists and antagonists bind to a common site in the CCK receptor.